Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02664922 · ClinicalTrials.gov registry record · Phase 4
Anesthetic Techniques in EP Patients
A Phase 4 study, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
NCT02664922 is a Phase 4 study that was terminated before completion, run by University of California, Los Angeles. The registered enrollment target is 35 participants.
The verdict
NCT02664922, a Phase 4 study, was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to compare different combinations of anesthetic drugs (cause loss of sensation) in terms of effectiveness, adverse effects, pain relief, and patient comfort for cardiac electrophysiology procedures. In addition, the investigators are studying the different anesthetic combinations to determine the best approach in terms of identification and treatment of arrhythmias.
Interventions
- DRUG Ketamine
- DRUG Sevoflurane
- DRUG Propofol
- DRUG Remifentanil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02664922
The ClinicalTrials.gov registry entry for NCT02664922 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Ketamine is the first listed.
NCT02664922 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02664922 about?
NCT02664922 is a clinical study titled "Anesthetic Techniques in EP Patients". The purpose of this study is to compare different combinations of anesthetic drugs (cause loss of sensation) in terms of effectiveness, adverse effects, pain relief, and patient comfort for cardiac electrophysiology procedures. In addition, the investigators are studying the different anesthetic com...
What is the current status of trial NCT02664922?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2012-05. Estimated completion is 2013-12.
What interventions are being tested in trial NCT02664922?
The interventions under investigation include: Ketamine (DRUG), Sevoflurane (DRUG), Propofol (DRUG), Remifentanil (DRUG).
Who is sponsoring clinical trial NCT02664922?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.